Study Reference No. C1C02199

Study Type Demographic Gender Age Location Compensation
Medicated Cream Healthy; Fitzpatrick skin type I-IV Males and Females 18 to 65 years Saint Petersburg FL $420
Study Details

Study Objective

The purpose of this study is to see how long a currently marketed skin ointment, Betnovate (Betamethasone valerate) ointment lmg/g by (Betnovate Salbe) GlaxoSmithKline Pharma GmbH; Vienna will lighten (whiten or blanch) the skin after the ointment is applied and to monitor the safety of the subjects. This will only be temporary (won't last).

Study Duration

The total duration of this study will be approximately 31 days (depending on date of screening visit 1) which includes 4 study visits: 2 screening visits, one optional visit and an overnight stay

Study Schedule

General Screening


Medical Screening

July 18, July 19

Study Visit(s)

Check-In: Sat Jul 23, Check-Out: Sun Jul 24

Follow-Up Visit(s)


Other Notes

Bring Valid Photo ID.